Request a chargeback if you were misled by false claims or did not receive the product
Management of T2D in older adults is complex due to the clinical, cognitive, and functional heterogeneity of this population, and, although some older adults with T2D may achieve disease control with oral glucose-lowering agents, many will require insulin as the disease progresses
For specific syringe guidance matched to your GLP-1 dosing, see our syringe dosage chart
In the Phase 2 trial, female participants at the 12mg dose lost an average of 25.3% at 48 weeks compared to 22.8% for males
Any patient currently on tirzepatide 15 mg who wants to trial retatrutide should discontinue tirzepatide first, allow at least two weeks for GI recovery, and begin retatrutide at the 2 mg starting dose with standard titration [2][4]
It reacts to signals that might indicate something toxic